For years, IQVIA has rigorously documented best practices in how pharmaceutical companies, medical device manufacturers and other industry firms collect and report data pertaining to HCP engagements.
Late in 2020, IQVIA surveyed key stakeholders at biotech, pharmaceutical and medical device manufacturers. The survey revealed pain points facing compliance individuals, showing the importance of enterprise-wide, scalable solutions that improve transparency reporting globally.
Download this white paper for insight into:- How transparency reporting is currently handled
- How compliance is evolving in life sciences
- A glimpse into what compliance professionals want (and need) with reporting solutions
- And how to leverage transparency data for improved ROI